Colloidal characteristics and formulation of pure protein particulate vaccines.

White, Paul J.; Hickey, Pascal; Sze Tu, Linda; Headey, Stephen J.; Scanlon, Martin J.; Boyd, Ben J.; Pouton, Colin W.

Objectives We recently reported that dense gas processing of the protein ovalbumin (OVA) resulted in the formation of particles that were insoluble in water and which retained their immunogenicity in vivo. In the present study, the colloidal properties of these pure protein particles were investigated to in part inform rational formulation approaches. Methods The colloidal properties of the particles, in terms of size, zeta potential and pH-dependent surface and solution properties, were examined. Key findings In phosphate-buffered saline (pH 7.4), flocculation of the particles was observed, which was prevented when particles were suspended in acetate buffer at pH lower than 4. The resulting particle size was 300 nm with low polydispersity and zeta potential of 22.9 ± 3.1 mV (mean ± SEM, n = 3) at pH 3. Dense gas OVA particles were also prevented from flocculation using steric stabilisation with Pluronic F127. In this form the particles were stable in Krebs-Henseleit solution for 48 h at room temperature. Conclusions These findings indicate that insoluble pure protein particles produced by dense gas processing have desirable characteristics as particulate vaccines, including consistency of particle size under controlled conditions and high colloid stability.

COLLOIDS; PROTEINS; VACCINES; OVALBUMINS; EGG whites

Journal of Pharmacy & Pharmacology, 2012, Vol 64, Issue 10, p1386

0022-3573

Academic Journal

10.1111/j.2042-7158.2012.01513.x